PRSS3 is a potential prognostic biomarker for lung adenocarcinoma

PRSS3 is significantly upregulated in LUAD and can be used as a marker for LUAD diagnosis and prognosis assessment. Further study of PRSS3 could provide valuable insight into the mechanisms underlying the occurrence and progression of LUAD.

Authors

Jie Wu (ORCID: https://orcid.org/0000-0002-0919-5380)
Xueqing Zhang
Lu Nie

Institutions

Jinzhou Medical University (CN)

Publication Details

Journal: Translational Cancer Research
Published: 2025-02-01
DOI: https://doi.org/10.21037/tcr-24-1556
Primary Topic: RNA modifications and cancer
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

PRSS3 is a potential prognostic biomarker for lung adenocarcinoma

Jie Wu, Xueqing Zhang, Lu Nie

Feb 1, 2025

Translational Cancer Research

RNA modifications and cancer

article

PRSS3 is a potential prognostic biomarker for lung adenocarcinoma

Jie Wu, Xueqing Zhang, Lu Nie

February 1, 2025article en

Abstract

Translational Cancer ResearchVol. 14(2)

Jinzhou Medical University (CN)

Good health and well-being

Openalex Percentile: Top 98%

RNA modifications and cancer

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PRSS3 is a potential prognostic biomarker for lung adenocarcinoma — Jie Wu, Xueqing Zhang, et al. · Translational Cancer Research (2025) | TGRS Research Map | TGRS